374 filings
Page 2 of 19
6-K
b77qnajoy75rsxv11y
7 Dec 23
BioNTech and Australia’s State of Victoria Sign Agreement on Strategic Partnership to Strengthen mRNA Ecosystem
8:17pm
6-K
51h k5lm1
7 Nov 23
1 Welcome & Introductory Remarks Ryan Richardson Chief Strategy Officer
8:03am
6-K
ekt krhpi940djcd
6 Nov 23
Current report (foreign)
6:54am
6-K
xvxwobo13of4sjsa7z
6 Nov 23
BioNTech Announces Third Quarter 2023 Financial Results
6:52am
6-K
u5lclmei
26 Oct 23
Pfizer and BioNTech Announce Positive Topline Data for Influenza and COVID-19
4:08pm
6-K
cuex55
23 Oct 23
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
4:16pm
6-K
mvmh7ojhm
16 Oct 23
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
6:14am
6-K
i1600loxgon
16 Oct 23
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
6:03am
144/A
1tfv9v2alffw mzkmp
10 Oct 23
Notice of proposed sale of securities (amended)
5:35pm
144
ix0ov3z ug2
29 Sep 23
Notice of proposed sale of securities
5:11pm
144
404x9cpkv9l a6yhq
29 Sep 23
Notice of proposed sale of securities
5:03pm
6-K
xh5xt4
11 Sep 23
Current report (foreign)
4:03pm
6-K
exm51qgv78tru
30 Aug 23
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
4:12pm
144/A
ibbi9zfrdlmywn
14 Aug 23
Notice of proposed sale of securities (amended)
5:18pm
6-K
od0m0ynyapakvdg54o
14 Aug 23
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
8:34am
6-K
gv8auettw h36d3
7 Aug 23
Current report (foreign)
8:02am
6-K
rz0r54s
7 Aug 23
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
6:06am
6-K
gkholf0r51ibvh4en
31 Jul 23
BioNTech Completes Acquisition of InstaDeep
8:12am
144
gemf99h12oqjze3o8
29 Jun 23
Notice of proposed sale of securities
4:52pm
6-K
n2c9a7
29 Jun 23
Current report (foreign)
7:09am